Parkinson's disease: Functional changes in frontal and parietal cortex using18F- fluoro-deoxy glucose positron emission tomography/computed tomography

Neurology India

Volumn 58, Issue 1, 2010, Pages 53-57

  Hou, Zhongyu ^a,b   Hong, Shuhui ^c   Sun, Bo ^a   Lin, Xiangtao ^a   Liu, Qingwei ^b   Yao, Shuzhan ^b   Liu, Shuwei ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

18F Fluorodeoxyglucose; Cat; Frontal and parietal cortex; Parkinson's disease; Positron emission tomography computed tomography

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; FLUORODEOXYGLUCOSE F 18;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR CHANGE; CAT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; FRONTAL CORTEX; FUNCTIONAL MORPHOLOGY; FUNCTIONAL STATUS; GLUCOSE METABOLISM; MALE; MOTOR PERFORMANCE; NONHUMAN; PARIETAL LOBE; PARKINSON DISEASE; QUANTITATIVE ANALYSIS;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CATS; DISEASE MODELS, ANIMAL; FLUORODEOXYGLUCOSE F18; FRONTAL LOBE; MALE; MPTP POISONING; NEUROTOXINS; PARIETAL LOBE; POSITRON-EMISSION TOMOGRAPHY; TIME FACTORS;

EID: 77949642574     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.60397     Document Type: Article

References (15)

1. Ingham CA, Hood SH, Taggart P, Arbuthnott GW. Plasticity of synapses in the rat neostriatum after unilateral lesion of the nigrostriatal dopaminergic pathway. J Neurosci 1998;18:4732-4743
2. Tang KC, Low MJ, Grandy DK, Lovinger DM. Dopamine-dependent synaptic plasticity in striatum during in vivo development. Proc Natl Acad Sci USA 2001;98:1255-1260
3. Huot P, Lévesque M, Parent A. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea. Brain 2007;130:22232
4. Obeso JA, Marin C, Rodriguez-Oroz C, Blesa J, Benitez-Temiño B, Mena-Segovia J, et al. The basal ganglia in Parkinson's disease: Current concepts and unexplained observations. Ann Neurol 2008;64:S30-46
5. Lang AE. When and how should treatment be started in Parkinson disease. Neurology 2009;72:39-43
6. Fukuda M, Edwards C, Eidelberg D. Functional brain networks in Parkinson's disease. Parkinsonism Relat Disord 2001;8:91-94
7. Carbon M, Felice Ghilardi M, Dhawan V, Eidelberg D. Correlates of movement initiation and velocity in Parkinson's disease: A longitudinal PET study. Neuroimage 2007;34:361-370
8. Rizk N, Downey RJ, Akhurst T, Gonen M, Bains MS, Larson S, et al. Preoperative 18[F]-fluorodeoxyglucose positron emission tomography standardized uptake values predict survival after esophageal adenocarcinoma resection. Ann Thorac Surg 2006;81:1076-1081
9. Kessler RM. Imaging methods for evaluating brain function in man. Neurobiol Aging 2003;24:21-35
10. Kikuchi A, Takeda A, Kimpara T, Nakagawa M, Kawashima R, Sugiura M, et al. Hypoperfusion in the supplementary motor area, dorsolateral prefrontal cortex and insular cortex in Parkinson's disease. J Neurol Sci 2001;193:29-36
11. Sabatini U, Boulanouar K, Fabre N, Martin F, Carel C, Colonnese C, et al. Cortical motor reorganization in akinetic patients with Parkinson's disease: A functional MRI study. Brain 2000;123:394-403
12. Haslinger B, Erhard P, Kampfe N, Boecker H, Rummeny E, Sch waiger M, et al. Event-related functional magnetic resonance imaging in Parkinson's disease before and after levodopa. Brain 2001;124:558-570
13. Buhmann C, Glauche V, Sturenburg HJ, Oechsner M, Weiller C, Buchel C. Pharmacologically modulated fMRI-cortical responsiveness to levodopa in drug-naive hemiparkinsonian patients. Brain 2003;126:451-461
14. Wu T, Hallett M. A functional MRI study of automatic movements in patients with Parkinson's disease. Brain 2005;128:2250-2259
15. Kalbe E, Voges J, Weber T, Haarer M, Baudrexel S, Klein JC, et al. Frontal FDG-PET activity correlates with cognitive outcome after STN-DBS in Parkinson disease. Neurology 2009;72:2-9